Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
Plasma concentrations of high density lipoprotein (HDL) cholesterol and its major apolipoprotein (apo)A-I are significantly decreased in inflammatory states. Plasma levels of the serum amyloid A (SAA) protein increase markedly during the acute phase response and are elevated in many chronic inflamma...
Main Authors: | Hiroshi Hosoai, Nancy R. Webb, Jane M. Glick, Uwe J.F. Tietge, Matthew S. Purdom, Frederick C. de Beer, Daniel J. Rader |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-04-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752032143X |
Similar Items
-
Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01) -
ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL
by: Jeffrey W. Chisholm, et al.
Published: (2002-01-01) -
Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01) -
Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
by: Konstantina Georgila, et al.
Published: (2019-08-01) -
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
by: Kuang-Yuh eChyu, et al.
Published: (2015-09-01)